New drug for MS
Apr 2, 2017 7:43:23 GMT -8
Post by kilg0retr0ut on Apr 2, 2017 7:43:23 GMT -8
The FDA has approved a new medication that is the first to treat a rare form of multiple sclerosis.
The FDA approved Ocrevus (ocrelizumab) Tuesday for primary progressive MS (PPMS), as well as the most common form of MS.
The FDA approved Ocrevus (ocrelizumab) Tuesday for primary progressive MS (PPMS), as well as the most common form of MS.
Read more: New MS Drug Approved By FDA
